These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 31893950)
1. Stabilization of Perivascular Mast Cells by Endothelial CNP (C-Type Natriuretic Peptide). Chen W; Werner F; Illerhaus A; Knopp T; Völker K; Potapenko T; Hofmann U; Frantz S; Baba HA; Rösch M; Zernecke A; Karbach S; Wenzel P; Kuhn M Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):682-696. PubMed ID: 31893950 [TBL] [Abstract][Full Text] [Related]
2. Endothelial C-Type Natriuretic Peptide Acts on Pericytes to Regulate Microcirculatory Flow and Blood Pressure. Špiranec K; Chen W; Werner F; Nikolaev VO; Naruke T; Koch F; Werner A; Eder-Negrin P; Diéguez-Hurtado R; Adams RH; Baba HA; Schmidt H; Schuh K; Skryabin BV; Movahedi K; Schweda F; Kuhn M Circulation; 2018 Jul; 138(5):494-508. PubMed ID: 29626067 [TBL] [Abstract][Full Text] [Related]
3. Auto/Paracrine C-Type Natriuretic Peptide/Cyclic GMP Signaling Prevents Endothelial Dysfunction. Werner F; Naruke T; Sülzenbrück L; Schäfer S; Rösch M; Völker K; Krebes L; Abeßer M; Möllmann D; Baba HA; Schweda F; Zernecke A; Kuhn M Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063044 [TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic peptide-mediated inhibition of microcirculatory endothelial Ca2+ and permeability response to histamine involves cGMP-dependent protein kinase I and TRPC6 channels. Chen W; Oberwinkler H; Werner F; Gaßner B; Nakagawa H; Feil R; Hofmann F; Schlossmann J; Dietrich A; Gudermann T; Nishida M; Del Galdo S; Wieland T; Kuhn M Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2121-9. PubMed ID: 23814119 [TBL] [Abstract][Full Text] [Related]
5. C-type natriuretic peptide is a Schwann cell-derived factor for development and function of sensory neurones. Kishimoto I; Tokudome T; Horio T; Soeki T; Chusho H; Nakao K; Kangawa K J Neuroendocrinol; 2008 Nov; 20(11):1213-23. PubMed ID: 18752656 [TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptide receptor-3 underpins the disparate regulation of endothelial and vascular smooth muscle cell proliferation by C-type natriuretic peptide. Khambata RS; Panayiotou CM; Hobbs AJ Br J Pharmacol; 2011 Sep; 164(2b):584-97. PubMed ID: 21457229 [TBL] [Abstract][Full Text] [Related]
7. Skeletal overgrowth-causing mutations mimic an allosterically activated conformation of guanylyl cyclase-B that is inhibited by 2,4,6,-trinitrophenyl ATP. Dickey DM; Otto NM; Potter LR J Biol Chem; 2017 Jun; 292(24):10220-10229. PubMed ID: 28450398 [TBL] [Abstract][Full Text] [Related]
8. The heart communicates with the endothelium through the guanylyl cyclase-A receptor: acute handling of intravascular volume in response to volume expansion. Schreier B; Börner S; Völker K; Gambaryan S; Schäfer SC; Kuhlencordt P; Gassner B; Kuhn M Endocrinology; 2008 Aug; 149(8):4193-9. PubMed ID: 18450968 [TBL] [Abstract][Full Text] [Related]
9. C-type natriuretic peptide regulation of guanosine-3',5'-cyclic monophosphate production in human endothelial cells. Rautureau Y; Gowers I; Wheeler-Jones CP; Baxter GF Auton Autacoid Pharmacol; 2010 Jul; 30(3):185-92. PubMed ID: 20085572 [TBL] [Abstract][Full Text] [Related]
10. A human skeletal overgrowth mutation increases maximal velocity and blocks desensitization of guanylyl cyclase-B. Robinson JW; Dickey DM; Miura K; Michigami T; Ozono K; Potter LR Bone; 2013 Oct; 56(2):375-82. PubMed ID: 23827346 [TBL] [Abstract][Full Text] [Related]
11. C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells. Rahmutula D; Gardner DG Endocrinology; 2005 Nov; 146(11):4968-74. PubMed ID: 16109786 [TBL] [Abstract][Full Text] [Related]
12. Ammonia inhibits the C-type natriuretic peptide-dependent cyclic GMP synthesis and calcium accumulation in a rat brain endothelial cell line. Konopacka A; Zielińska M; Albrecht J Neurochem Int; 2008 May; 52(6):1160-6. PubMed ID: 18222015 [TBL] [Abstract][Full Text] [Related]
13. Characterization of natriuretic peptide receptor subtypes in the AtT-20 pituitary tumour cell line. Gilkes AF; Ogden PH; Guild SB; Cramb G Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):481-7. PubMed ID: 8172609 [TBL] [Abstract][Full Text] [Related]
14. C-type natriuretic peptide (CNP)/guanylate cyclase B (GC-B) system and endothelin-1(ET-1)/ET receptor A and B system in human vasculature. Taura D; Nakao K; Nakagawa Y; Kinoshita H; Sone M; Nakao K Can J Physiol Pharmacol; 2020 Sep; 98(9):611-617. PubMed ID: 32268070 [TBL] [Abstract][Full Text] [Related]
15. C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness. Michel K; Herwig M; Werner F; Špiranec Spes K; Abeßer M; Schuh K; Dabral S; Mügge A; Baba HA; Skryabin BV; Hamdani N; Kuhn M JCI Insight; 2020 Nov; 5(22):. PubMed ID: 33055420 [TBL] [Abstract][Full Text] [Related]
16. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice. Pierkes M; Gambaryan S; Bokník P; Lohmann SM; Schmitz W; Potthast R; Holtwick R; Kuhn M Cardiovasc Res; 2002 Mar; 53(4):852-61. PubMed ID: 11922895 [TBL] [Abstract][Full Text] [Related]
20. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging. Kaneki H; Kurokawa M; Ide H J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]